Which are the causes of Adrenal Cortical Carcinoma (ACC)?

TL;DR: Adrenal Cortical Carcinoma (ACC) is a rare, aggressive cancer that arises from the outer layer of the adrenal gland, and its exact cause remains largely unknown in most sporadic cases. While the majority of cases occur randomly, a subset is linked to specific hereditary genetic syndromes that predispose individuals to tumor development.

What are the primary genetic factors linked to Adrenal Cortical Carcinoma?

While most cases of Adrenal Cortical Carcinoma are sporadic, meaning they occur without a family history, genetic research has identified key drivers. Approximately 15% to 20% of children with Adrenal Cortical Carcinoma possess an underlying genetic predisposition, most notably Li-Fraumeni syndrome, caused by a germline mutation in the TP53 gene. This gene acts as a "guardian of the genome," and when it is mutated, the body struggles to repair damaged DNA, allowing cells to grow uncontrollably.

Are there known environmental or metabolic risk factors for Adrenal Cortical Carcinoma?

Unlike many common cancers, there are no well-defined environmental triggers—such as smoking or diet—that are definitively linked to the development of Adrenal Cortical Carcinoma. Research is ongoing to determine if there are specific metabolic or hormonal triggers that initiate the transformation of normal adrenal cells into malignant ones. Current scientific understanding categorizes risk factors into two groups:

• Hereditary Syndromes: Conditions like Li-Fraumeni, Beckwith-Wiedemann, and Multiple Endocrine Neoplasia type 1 (MEN1).


• Somatic Mutations: Non-hereditary mutations that occur within the tumor itself, such as alterations in the Wnt/β-catenin signaling pathway, which are found in about 30% to 50% of Adrenal Cortical Carcinoma cases.

How does current research approach the etiology of this disease?

The etiology of Adrenal Cortical Carcinoma is still under intense investigation. Researchers are using genomic sequencing to map the molecular landscape of Adrenal Cortical Carcinoma to identify why these tumors become so aggressive. By studying these 265 community members and global patient cohorts, scientists hope to move beyond broad categories and identify specific biomarkers that could explain why the disease manifests differently in each patient.

Next steps

• Consult with an endocrinologist or an oncologist specializing in rare adrenal malignancies.


• Request a referral to a genetic counselor if you have a family history of endocrine tumors or early-onset cancers.


• Connect with the 265 members of the DiseaseMaps.org Adrenal Cortical Carcinoma community to share experiences and find emotional support.


• Inquire about clinical trials investigating targeted molecular therapies for advanced disease.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding any medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Adrenal Cortical Carcinoma


• Orphanet: Adrenocortical carcinoma


• OMIM (Online Mendelian Inheritance in Man): Adrenocortical Carcinoma


• American Association of Endocrine Surgeons (AAES) Patient Education